ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018
Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 27 citations in OpenAlex.
- Noninvasive renal mass diagnostic models based on radiomic features and clinical data: a multi-center study.Abdominal radiology (New York) · 2026Article
- Renal oncocytoma: Α case report and literature review.Oncotarget · 2026Review
- An interpretable machine learning model for preoperative prediction of renal mass malignancy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Oncological Outcomes of Non-clear Cell Renal Cell Carcinomas: A Retrospective Study From a Tertiary Care Center.Cureus · 2025Article
- Article
- Peak early-phase enhancement ratio on contrast-enhanced MRI to differentiate chromophobe renal cell carcinoma from oncocytoma.BJUI compass · 2025Article
- Using deep learning to differentiate among histology renal tumor types in computed tomography scans.BMC medical imaging · 2025Article
- Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report.JCO precision oncology · 2024Article
- Convolutional neural networks for the differentiation between benign and malignant renal tumors with a multicenter international computed tomography dataset.Insights into imaging · 2024Article
- A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia.Scientific reports · 2023Article
- [Artificial intelligence in urology-opportunities and possibilities].Urologie (Heidelberg, Germany) · 2023Review
- Stability of renal parenchymal volume and function during active surveillance of renal oncocytoma patients.Urologic oncology · 2023Article
- Deep learning techniques for imaging diagnosis of renal cell carcinoma: current and emerging trends.Frontiers in oncology · 2023Review
- Smoking enhanced the expression of c-kit in chromophobe renal cell carcinoma.Tobacco induced diseases · 2023Article
- Differentiating Oncocytic Renal Tumors from Chromophobe Renal Cell Carcinoma: Comparison of Peak Early-phase Enhancement Ratio to Clinical Risk Factors and Rater Predictions.European urology open science · 2022Article
- Review
- 2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses.Societe internationale d'urologie journal : SIUJ · 2022Article
- Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.Diagnostics (Basel, Switzerland) · 2022Article
- A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.The British journal of radiology · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.